| 11.04.2024 13:18 | OCTP | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | Alliance |
| 11.04.2024 11:26 | OCTP | Appointment of Phase I Clinical Trial CRO | RNS |
| 03.04.2024 08:00 | OCTP | OCT Company Update with Doceo | Reach |
| 26.03.2024 10:56 | OCTP | Oxford Cannabinoid Technologies video with Doceo | Reach |
| 18.03.2024 07:00 | OCTP | Appointment of Hybridan as Adviser | RNS |
| 29.02.2024 07:02 | OCTP | Directorate Appointment | RNS |
| 29.02.2024 07:01 | OCTP | Directorate Changes | RNS |
| 29.02.2024 07:00 | OCTP | Total Voting Rights | RNS |
| 28.02.2024 17:35 | OCTP | TR-1: NOTIFICATION OF MAJOR HOLDINGS | RNS |
| 28.02.2024 17:34 | OCTP | TR-1: NOTIFICATION OF MAJOR HOLDINGS | RNS |
| 28.02.2024 17:34 | OCTP | TR-1: NOTIFICATION OF MAJOR HOLDINGS | RNS |
| 26.02.2024 13:07 | OCTP | Directors’ Dealings | RNS |
| 19.02.2024 13:52 | OCTP | Result of General Meeting | RNS |
| 16.02.2024 14:36 | OCTP | IN BRIEF: Oxford Cannabinoid completes capital reorganisation | Alliance |
| 16.02.2024 07:00 | OCTP | Completion of Capital Reorganisation | RNS |
| 15.02.2024 11:54 | OCTP | IN BRIEF: Oxford Cannabinoid shares up on applying to admit new shares | Alliance |
| 15.02.2024 07:00 | OCTP | Subscription | RNS |
| 14.02.2024 19:55 | OCTP | IN BRIEF: Oxford Cannabinoid applies for new shares to be listed | Alliance |
| 14.02.2024 12:53 | OCTP | Capital Reorganisation | RNS |
| 12.02.2024 14:04 | RESI, OCTP, EISB | UK shareholder meetings calendar - next 7 days | Alliance |
| 02.02.2024 15:56 | OCTP | IN BRIEF: Oxford Cannabinoid agrees GBP565,000 loan notes deal | Alliance |
| 30.01.2024 11:27 | OCTP | Oxford Cannabinoid Technologies down after GBP1.2 million fundraise | Alliance |
| 30.01.2024 07:04 | OCTP | Fundraising and Proposed Capital Reorganisation | RNS |
| 30.01.2024 07:02 | OCTP | R&D Tax Credit | RNS |
| 30.01.2024 07:00 | OCTP | Half-year Report | RNS |
| 23.01.2024 14:32 | SYNT, STEM, SSPG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 23.01.2024 07:00 | OCTP | Notice of Results | RNS |
| 10.01.2024 11:46 | OCTP | IN BRIEF: Oxford Cannabinoid stock goes high on Europe patent filing | Alliance |
| 10.01.2024 07:00 | OCTP | Patent Applications | RNS |
| 14.11.2023 07:00 | OCTP | Directorate Appointment | RNS |
| 24.10.2023 07:00 | OCTP | TR-1: Notification of major holdings | RNS |
| 20.10.2023 09:37 | OCTP | IN BRIEF: Kingsley Capital reduces stake in Oxford Cannabinoid | Alliance |
| 20.10.2023 07:01 | OCTP | TR-1: Notification of major holdings | RNS |
| 20.10.2023 07:00 | OCTP | Director Dealing | RNS |
| 10.10.2023 11:34 | OCTP | Oxford Cannabinoid completes Phase 1 study for lead asset OCT461201 | Alliance |
| 10.10.2023 07:00 | OCTP | Phase I Clinical Trial Results | RNS |
| 29.09.2023 07:00 | OCTP | Result of AGM | RNS |
| 25.09.2023 10:41 | OCTP | Oxford Cannabinoid issues final dose of lead pharmaceutical asset | Alliance |
| 25.09.2023 07:00 | OCTP | Final Dose Administered | RNS |
| 21.09.2023 15:50 | ZOO, TRU, REVB | UK shareholder meetings calendar - next 7 days | Alliance |
| 05.09.2023 16:18 | OCTP | Notice of AGM | RNS |
| 31.08.2023 17:40 | OCTP, NAVF, IDHC | EARNINGS SUMMARY: Gulf Keystone swings to loss; Gulf Marine optimistic | Alliance |
| 31.08.2023 09:53 | OCTP, PALM, ALFA | SMALL-CAP WINNERS & LOSERS: PPHE Hotels rises on swing to profit | Alliance |
| 31.08.2023 07:00 | OCTP | 2023 Final Results | RNS |
| 24.08.2023 15:47 | SOM, REVB, PBEE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 22.08.2023 07:00 | OCTP | Notice of Results | RNS |
| 27.07.2023 18:22 | OCTP, MILA, ADT1 | TRADING UPDATES: Pod Point cuts outlook; CVS Group buys in Australia | Alliance |
| 27.07.2023 07:00 | OCTP | First Dose Administered & Pain Specialist Adviser | RNS |
| 17.07.2023 13:16 | OCTP | Director/PDMR Share Purchases | RNS |
| 17.07.2023 10:30 | OCTP | Oxford Cannabinoid expands into oncology; discovers tumour treatment | Alliance |
| 17.07.2023 07:00 | OCTP | Expansion into oncology | RNS |
| 12.07.2023 07:00 | OCTP | Investor Presentation and Q&A – Programmes update | Reach |
| 15.06.2023 09:50 | OCTP | OCTP update from Doceo | Reach |
| 08.06.2023 12:36 | OCTP | IN BRIEF: Oxford Cannabinoid appoints Nodenza's Tim Corn as new CMO | Alliance |
| 08.06.2023 07:00 | OCTP | Appointment of Chief Medical Officer | RNS |
| 17.05.2023 19:46 | OCTP | IN BRIEF: Oxford Cannabinoid clinical trial application approved | Alliance |
| 17.05.2023 07:00 | OCTP | MHRA & REC 2 Approval for Phase 1 Clinical Trial | RNS |
| 12.04.2023 14:20 | OCTP | IN BRIEF: Oxford Cannabinoid shares up as Sowemimo-Coker named CEO | Alliance |
| 12.04.2023 07:00 | OCTP | Directorate Change, Renewal of Licence & Update | RNS |
| 14.03.2023 14:05 | OCTP | Second Price Monitoring Extn | RNS |
| 14.03.2023 14:00 | OCTP | Price Monitoring Extension | RNS |
| 13.03.2023 16:35 | OCTP | Price Monitoring Extension | RNS |
| 07.03.2023 11:05 | OCTP | Second Price Monitoring Extn | RNS |
| 07.03.2023 11:00 | OCTP | Price Monitoring Extension | RNS |
| 06.03.2023 11:05 | OCTP | Second Price Monitoring Extn | RNS |
| 06.03.2023 11:00 | OCTP | Price Monitoring Extension | RNS |
| 25.01.2023 12:09 | OCTP | Holding in Company | RNS |
| 23.01.2023 14:17 | OCTP | Oxford Cannabinoid interim loss nearly doubles as research costs surge | Alliance |
| 23.01.2023 07:00 | OCTP | Half-year Report | RNS |
| 16.01.2023 15:38 | OCTP | UK earnings, trading statements calendar - next 7 days | Alliance |
| 16.01.2023 07:00 | OCTP | Appointment of General Counsel & Notice of Results | RNS |
| 12.01.2023 21:20 | MVI, LND, PXC | TRADING UPDATES: Arkle finds pegmatites; Apollon win license deal | Alliance |
| 12.01.2023 07:00 | OCTP | Update on combined Clinical Trial Application | RNS |
| 05.01.2023 12:27 | OCTP | IN BRIEF: Oxford Cannabinoid submits trials application for agonist | Alliance |
| 05.01.2023 10:46 | OCTP | Submission of combined Clinical Trial Application | RNS |
